A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL

Authors

  • Ambili Remesh Department of Pharmacology Dr. Somervell Memorial CSI Medical College Karakonam, Trivandrum, Kerala

DOI:

https://doi.org/10.3329/icpj.v1i10.11850

Keywords:

Intermediate grade NHL, CHOP chemotherapy, toxicity profile

Abstract

Cancer chemotherapy engenders a gamut of unpredictable and perilous toxicities, which can cause substantialmortality, morbidity, and results in escalated healthcare costs due to increased requirement for ameliorative treat-ments and toxicity-related hospitalization. The main objective of this article is to report a range of adverse effects ofCHOP regimen in patients with intermediate grade Non-Hodgkins Lymphoma (NHL). This randomized prospective study was conducted on de novo intermediate grade NHL patients, aged >20?60 years, receiving CHOP chemotherapyregimen. Out of 30 patients who satisfied the inclusion criteria, only 25 patients completed 6 cycles of chemotherapy and were evaluated for various toxicities. Evaluation of all the 25 subjects showed that, in comparison with the baseline, most patients exhibited toxic damages. The hepatopancreatic, dermatological, vascular and nephrologicaldamages, eventually resulted in weight loss, hepatomegaly, alopecia, hypotension, as well as abnormal levels of serum liver markers, serum creatinine and blood glucose. But, the necessity to interrupt the CHOP treatment did not arise in any of the patients. Thus, in this study combination chemotherapy with CHOP protocol was well tolerated by majority of the subjects.

DOI: http://dx.doi.org/10.3329/icpj.v1i10.11850

International Current Pharmaceutical Journal 2012, 1(10): 322-327

Downloads

Download data is not yet available.
Abstract
113
PDF
148

Downloads

Published

2012-09-05

How to Cite

Remesh, A. (2012). A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL. International Current Pharmaceutical Journal, 1(10), 322–327. https://doi.org/10.3329/icpj.v1i10.11850

Issue

Vol. 1 No. 10 (2012)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).